Brief: Cumberland Pharmaceuticals - New Study Reveals Superiority Of Vibativ Over Vancomycin
15/10/2019 14:52
Oct 15 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS INC - NEW STUDY REVEALS
SUPERIORITY
OF VIBATIV OVER VANCOMYCIN IN SELECT PATIENTS WITH BACTERIAL
PNEUMONIA
Source text for Eikon: ID:nPn6xf1YWa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM